Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII

被引：65

作者：

Vlot, AJ

Ton, E

Mackaay, AJC

Kramer, MHH

Gaillard, CAJM ^{[1
]}

机构：

[1] Eemland Hosp, Dept Internal Med, NL-3818 ES Amersfoort, Netherlands

[2] Eemland Hosp, Dept Surg, NL-3818 ES Amersfoort, Netherlands

来源：

AMERICAN JOURNAL OF MEDICINE | 2000年 / 108卷 / 05期

关键词：

D O I：

10.1016/S0002-9343(99)00398-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：421 / 423

页数：3

共 9 条

[1]

HEDNER U, 1988, LANCET, V2, P1193

[2]

Kristensen J, 1996, HAEMOSTASIS, V26, P159

[3] MEDICAL PROGRESS - BLEEDING PEPTIC-ULCER [J].

LAINE, L ;

PETERSON, WL .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (11) :717-727

[4]

Lusher JM, 1996, HAEMOSTASIS, V26, P124

[5]

Meijer K, 1998, THROMB HAEMOSTASIS, V80, P204

[6]

Peters M, 1998, THROMB HAEMOSTASIS, V80, P352

[7]

RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7

[8] THE ACTIVATION OF FACTOR-X AND PROTHROMBIN BY RECOMBINANT FACTOR VIIA IN-VIVO IS MEDIATED BY TISSUE FACTOR [J].

TENCATE, H ;

BAUER, KA ;

LEVI, M ;

EDGINGTON, TS ;

SUBLETT, RD ;

BARZEGAR, S ;

KASS, BL ;

ROSENBERG, RD .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1207-1212

[9]

Tengborn L, 1996, THROMB HAEMOSTASIS, V75, P981

← 1 →